CHI3L1 and neoplasm: Indeed, general CLP blockade provided an enhanced reduction in primary tumor growth compared to anti-CHI3L1 treatment in the 4T1-based model, reduced immunosuppressive myeloid populations and T-reg production to a higher extent, and also increased anti-tumorigenic CD8α+ T-cell numbers and their activity to a higher level.